Free Trial

Calithera Biosciences (CALA) Competitors

Calithera Biosciences logo
$0.0001 0.00 (0.00%)
As of 07/7/2025 12:25 PM Eastern

CALA vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUW

Should you be buying Calithera Biosciences stock or one of its competitors? The main competitors of Calithera Biosciences include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

Calithera Biosciences vs. Its Competitors

Calithera Biosciences (NASDAQ:CALA) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, institutional ownership, risk, analyst recommendations, media sentiment and profitability.

Company Net Margins Return on Equity Return on Assets
Calithera BiosciencesN/A N/A N/A
180 Life Sciences N/A N/A N/A

In the previous week, Calithera Biosciences' average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
Calithera Biosciences Neutral
180 Life Sciences Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Calithera BiosciencesN/AN/A-$39.65MN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Summary

Calithera Biosciences and 180 Life Sciences tied by winning 0 of the 0 factors compared between the two stocks.

Get Calithera Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for CALA and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CALA vs. The Competition

MetricCalithera BiosciencesPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market CapN/A$784.82M$5.52B$9.02B
Dividend YieldN/A4.84%5.24%4.08%
P/E RatioN/A1.3027.1920.04
Price / SalesN/A230.49413.81108.84
Price / CashN/A23.4426.2128.59
Price / BookN/A6.237.925.55
Net Income-$39.65M-$27.94M$3.17B$248.49M
7 Day PerformanceN/A2.40%1.78%4.87%
1 Month PerformanceN/A8.93%1.26%6.63%
1 Year PerformanceN/A8.65%33.30%20.38%

Calithera Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CALA
Calithera Biosciences
N/A$0.00
flat
N/A-99.0%$0.00N/A0.0060
ATNFW
180 Life Sciences
N/A$0.01
-2.4%
N/A-4.6%$0.00N/A0.007Positive News
Gap Up
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.01
flat
N/A-80.9%$0.00N/A0.002
AIMDW
Ainos
N/A$0.18
+6.1%
N/AN/A$0.00$106.21K0.0040Gap Down
ALVOW
Alvotech
N/A$1.73
+1.8%
N/A-36.2%$0.00$585.60M0.004Positive News
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.03
+6.5%
N/AN/A$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.09
-14.6%
N/A+157.7%$0.00$38.00M0.0070Positive News
Gap Up
BTMDW
biote
N/A$0.02
-41.2%
N/AN/A$0.00$199.38M0.00N/AGap Down
BCTXW
BriaCell Therapeutics
N/A$0.07
+7.0%
N/A-71.1%$0.00N/A0.008
CELUW
Celularity
N/A$0.04
-20.3%
N/A+80.5%$0.00$54.22M0.00220Positive News

Related Companies and Tools


This page (NASDAQ:CALA) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners